Approval · Notice of Compliance 5902 · 2004
ECOSTATIN: Notice of Compliance 5902
Issued November 17, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5902
- Date
- November 17, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antifungal agent
Products in this notice
Medicinal ingredients
- ECONAZOLE NITRATE 1 PER
- ECONAZOLE NITRATE 150 MG per SUP